CC BY-NC-ND 4.0 · South Asian J Cancer 2019; 08(03): 185-188
DOI: 10.4103/sajc.sajc_87_19
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
Sachin Dhumal
Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
,
Arun Chandrasekharan
Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
,
Vijay Patil
Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
,
Vanita Noronha
Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
,
Amit Joshi
Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
,
Ameya Puranik
Department of Nuclear Medicine, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
,
Venkatesh Rangarajan
Department of Nuclear Medicine, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
,
Kumar Prabhash
Department of Nuclear Medicine, Tata Memorial Centre, HBNI, Mumbai, Maharashtra
› Author Affiliations
Financial support and sponsorship Nil.
Publication History
Article published online:
21 December 2020
© 2019. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
-
1 Stenner M, Klussmann JP. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. Eur Arch Otorhinolaryngol 2009;266:333-41.
-
2 Wang X, Luo Y, Li M, Yan H, Sun M, Fan T, et al. Management of salivary gland carcinomas – A review. Oncotarget 2017;8:3946-56.
-
3 Patil VM, Prabhash K, Noronha V, Joshi A, Muddu V, Dhumal S, et al. Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers. Oral Oncol 2014;50:1000-4.
-
4 Ho K, Lin H, Ann DK, Chu PG, Yen Y. An overview of the rare parotid gland cancer. Head Neck Oncol 2011;3:40.
-
5 Licitra L, Cavina R, Grandi C, Palma SD, Guzzo M, Demicheli R, et al. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann Oncol 1996;7:640-2.
